Similar articles

• Involvement of oxidants and AP-1 in angiotensin II-activated NFAT3 transcription factor.

  Tu VC, Sun H, Bowden GT, Chen QM. Tu VC, et al. Am J Physiol Cell Physiol. 2007 Apr;292(4):C1248-55. doi: 10.1152/ajpcell.00624.2005. Epub 2006 Nov 15. Am J Physiol Cell Physiol. 2007. PMID: 17108007
• [CaN-NFAT3 signal pathway: a crucial hinge relates Ca2+ signal with cardiomyocyte hypertrophy].

  Zhu SJ, Yang YJ, Yu LJ, Huang L. Zhu SJ, et al. Zhonghua Nei Ke Za Zhi. 2004 Jan;43(1):19-21. Zhonghua Nei Ke Za Zhi. 2004. PMID: 14990015 Chinese.
• Tissue type-specific modulation of ER transcriptional activity by NFAT3.

  Zhang H, Wang X, Li J, Zhu J, Xie X, Yuan B, Yang Z, Zeng M, Jiang Z, Li J, Huang C, Ye Q. Zhang H, et al. Biochem Biophys Res Commun. 2007 Feb 16;353(3):576-81. doi: 10.1016/j.bbrc.2006.12.046. Epub 2006 Dec 18. Biochem Biophys Res Commun. 2007. PMID: 17194453
• Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.

  Liu J, Zhuang T, Pi J, Chen X, Zhang Q, Li Y, Wang H, Shen Y, Tomlinson B, Chan P, Yu Z, Cheng Y, Zheng X, Reilly M, Morrisey E, Zhang L, Liu Z, Zhang Y. Liu J, et al. Circulation. 2019 Aug 20;140(8):665-680. doi: 10.1161/CIRCULATIONAHA.119.039767. Epub 2019 Jun 10. Circulation. 2019. PMID: 31177814
• Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.

  Chen Y, Yuan J, Jiang G, Zhu J, Zou Y, Lv Q. Chen Y, et al. Mol Med Rep. 2017 Oct;16(4):4545-4552. doi: 10.3892/mmr.2017.7211. Epub 2017 Aug 10. Mol Med Rep. 2017. PMID: 28849081 Free PMC article.